Evidence map›Paper›PMID 35715956›Full record

Observational studyESC heart failure2022

Impact of patient engagement in a French telemonitoring programme for heart failure on hospitalization and mortality.

Rémi Sabatier, Damien Legallois, Mouna Jodar, Laurène Courouve, Valérie Donio, Florence Boudevin, Thibault De Chalus, Karine Hauchard, Annette Belin, Paul Milliez

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. High-intensity care for GDMT titration.Heart failure reviews · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Rémi SabatierService de Cardiologie et de Pathologie Vasculaire, CHU Caen Normandie, Avenue Côte de Nacre, 14000, Caen, France.
Damien LegalloisService de Cardiologie et de Pathologie Vasculaire, CHU Caen Normandie, Avenue Côte de Nacre, 14000, Caen, France.
Mouna JodarService de Cardiologie et de Pathologie Vasculaire, CHU Caen Normandie, Avenue Côte de Nacre, 14000, Caen, France.
Laurène CourouveCemka, Bourg-la-Reine, France.
Valérie DonioCemka, Bourg-la-Reine, France.
Florence BoudevinAmgen, Boulogne-Billancourt, France.
Thibault De ChalusAmgen, Boulogne-Billancourt, France.
Karine HauchardNormand'e-santé, Caen, France.
Annette BelinService de Cardiologie et de Pathologie Vasculaire, CHU Caen Normandie, Avenue Côte de Nacre, 14000, Caen, France.
Paul MilliezService de Cardiologie et de Pathologie Vasculaire, CHU Caen Normandie, Avenue Côte de Nacre, 14000, Caen, France.
Centre Hospitalier Universitaire de Caen Normandie · FRUniversité de Caen Normandie · FRCemka-Eval (France) · FRLaboratoire Vision Action Cognition · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsManagement of patients with recently decompensated heart failure by hospital services is expensive, complicated to plan, and not always effective. Telemedicine programmes in heart failure may improve the quality of care, but their effectiveness is poorly documented in real-world settings. The study aims to evaluate the impact of patient engagement in home-based telemonitoring for heart failure (SCAD programme) on rehospitalization and mortality rates. METHODS AND

resultsA retrospective observational study was performed in 659 SCAD participants. SCAD is a patient-oriented service of home-based interactive telemonitoring offered to heart failure patients during hospitalization who agree to participate in a therapeutic education programme. Patients were telemonitored for at least 3 months, and rehospitalization and mortality were documented at 12 months and 5 years. During the telemonitoring period, patients provided daily information on health and lifestyle through an internet-based interface. Data were linked on a patient-by-patient basis between the SCAD database and the French national health insurance database (Système National des Données de Santé). Outcomes were compared as a function of use of the programme. Low, intermediate, and high users were classified by tercile of data return during telemonitoring. Patients were followed for a median of 32.9 months. Rehospitalization rates for cardiovascular disease decreased from 79.4% in the year preceding enrolment to 41.1% in the following year and from 52.8% to 18.8% for hospitalizations for heart failure. The 12 month mortality rate was 11.2%. Significant associations were observed between level of use of the SCAD programme and all-cause rehospitalization (P = 0.0085), rehospitalization for cardiovascular disease (P = 0.0010), rehospitalization for heart failure (27.8% in low users, 12.9% in intermediate users, and 13.5% in high users; P < 0.0001), and mortality (26.8%, 15.2%, and 15.9% respectively; P = 0.0157) in the 12 months following enrolment. The mean number of days alive outside hospital were 279 ± 111 in low users, 312 ± 90 in intermediate users, and 304 ± 100 in high users (P = 0.0022).

conclusionsEducational home telemonitoring of patients with heart failure following hospitalization provides long-term clinical benefits in terms of rehospitalization and death in real-world settings, according to the level of use of the programme by the patient. These benefits would be expected to have a major impact on the burden of this disease. Low engagement in telemonitoring could be used as a signal of poor prognosis and taken into account in the management strategy.

Indexed as

Cardiovascular DiseasesHeart FailureTelemedicineHospitalizationHumansPatient ParticipationCardiovascular diseaseHeart failureHospitalizationMortalityTelemedicine

Identifiers

PMID35715956
PMCPMC9715861
OpenAlexW4283076820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.